Dong Xu Qiu
Founder bei CANSINO BIOLOGICS INC.
Profil
Dong Xu Qiu gründete CanSino Biologics, Inc. Er ist Mitglied des Vorstands von CanSino Biologics, Inc. und Senior Advisor bei ChinaBio LLC. Dr. Qiu promovierte an der Universität Peking, erwarb einen MBA an der University of Western Ontario, einen Bachelor-Abschluss an der Shenyang Pharmaceutical University, einen Doktortitel an der Universität Konstanz und einen Doktortitel an der University of Montral.
Aktive Positionen von Dong Xu Qiu
| Unternehmen | Position | Beginn |
|---|---|---|
| CANSINO BIOLOGICS INC. | Founder | 13.01.2009 |
Suzhou GenePharma Co., Ltd.
 Suzhou GenePharma Co., Ltd. BiotechnologyHealth Technology Suzhou GenePharma Co.,Ltd. engages in the manufacture of biotechnology products. Its products cover chemically-synthetic RNA monomer, RNA oligo synthesis, and the relevant modifiers, labeling, and fluorescein reagents. The company was founded on August 27, 2007 and is headquartered in Shanghai, China. | Director/Board Member | - |
Ehemalige bekannte Positionen von Dong Xu Qiu
| Unternehmen | Position | Ende |
|---|---|---|
ChinaBio LLC
 ChinaBio LLC Financial ConglomeratesFinance ChinaBio LLC operates as an investment, consulting and media company which helps life science companies. It organizes life science investment and partnering conferences in China. The firm’s conferences comprise investor forums, partnering forums, executive workshops and SEED business plan competitions. It also offers consulting services, including China strategy development, market and competitive intelligence, technology survey and search, partnering arrangement, CRO and CMO selection, management, business strategy, funding strategy, assistance, collaboration agreements, in-licensing, out-licensing, the United States operations consulting services, investment analysis, due diligence and portfolio analysis. The company serves executives, entrepreneurs, investors, pharma and multinational companies. ChinaBio was founded in April 2007 by Greg B. Scott and James W. Larrick and is headquartered in Shanghai, China. | Corporate Officer/Principal | 01.04.2011 |
Arius Research, Inc.
 Arius Research, Inc. BiotechnologyHealth Technology Arius Research, Inc. develops anti-cancer antibodies. The company is headquartered in Toronto, Canada. | Corporate Officer/Principal | 01.01.2002 |
Ausbildung von Dong Xu Qiu
| Peking University | Doctorate Degree |
| University of Western Ontario | Masters Business Admin |
| University of Montréal | Doctorate Degree |
| Universität Konstanz | Doctorate Degree |
| Shenyang Pharmaceutical University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| CANSINO BIOLOGICS INC. | Health Technology |
 | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Arius Research, Inc.
Arius Research, Inc. BiotechnologyHealth Technology Arius Research, Inc. develops anti-cancer antibodies. The company is headquartered in Toronto, Canada. | Health Technology |
ChinaBio LLC
ChinaBio LLC Financial ConglomeratesFinance ChinaBio LLC operates as an investment, consulting and media company which helps life science companies. It organizes life science investment and partnering conferences in China. The firm’s conferences comprise investor forums, partnering forums, executive workshops and SEED business plan competitions. It also offers consulting services, including China strategy development, market and competitive intelligence, technology survey and search, partnering arrangement, CRO and CMO selection, management, business strategy, funding strategy, assistance, collaboration agreements, in-licensing, out-licensing, the United States operations consulting services, investment analysis, due diligence and portfolio analysis. The company serves executives, entrepreneurs, investors, pharma and multinational companies. ChinaBio was founded in April 2007 by Greg B. Scott and James W. Larrick and is headquartered in Shanghai, China. | Finance |
